том 21 издание 3 страницы 410-418

Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity

Mohammed M. Al-Mahadeen 1, 2
Areej Majed Jaber 3
Belal O. Al-Najjar 3, 4
Monther A. Khanfar 1, 2, 5
Mustafa M. El-Abadelah 1, 2
Тип публикацииJournal Article
Дата публикации2025-02-01
scimago Q3
wos Q2
БС3
SJR0.377
CiteScore4.0
Impact factor2.5
ISSN15701794, 18756271
Краткое описание
Background:

A direct synthesis of functionalized dimethyl fumarate derivatives of 2-(2-((E)-(2-oxoindolin-3-ylidene)methyl)-1H-benzo[d]imidazol-1-yl) is achieved via one-pot reac-tion involving 2-methyl-1H-benzo[d]imidazole and appropriate isatin in the presence of DMAD.

Methods:

Conversely, this one-pot reaction furnished, upon conduction at 60 o C, the 2-(2-((E)-(2-oxoindolin-3-ylidene)methyl)-1H-benzo[d]imidazol-1-yl) products. The biological activities were evaluated against JNK3 kinase. We chose to dock the compounds into the JNK3 binding site in order to comprehend the molecular underpinnings of the observed bioactivities.

Results:

The structures of the synthesized compound adduct were evidenced from NMR and MS spectral data and further confirmed by single-crystal X-ray diffraction. The biological activities revealing that the introduction of an alkyl group at the 1-position of the isatin moiety produced JNK3 inhibitors with IC50 values in the low micromolar range.

Conclusion:

This study synthesized a unique compound using a three-component method. Com-pound 4d showed high antitumor activity (IC50 = 6.5 μM) against JNK3 inhibitors, while com-pounds 4c, 4d, and 4f exhibited high selectivity. The research highlights the effectiveness of the one-pot reaction in creating medically useful hybrid compounds, marking a significant advance in medicinal chemistry.

Найдено 
Найдено 

Топ-30

Журналы

1
Pharmacia
1 публикация, 33.33%
Russian Chemical Reviews
1 публикация, 33.33%
Mini-Reviews in Organic Chemistry
1 публикация, 33.33%
1

Издатели

1
Pensoft Publishers
1 публикация, 33.33%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 33.33%
Bentham Science Publishers Ltd.
1 публикация, 33.33%
1
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
3
Поделиться
Цитировать
ГОСТ |
Цитировать
Al-Mahadeen M. M. et al. Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity // Current Organic Synthesis. 2025. Vol. 21. No. 3. pp. 410-418.
ГОСТ со всеми авторами (до 50) Скопировать
Al-Mahadeen M. M., Jaber A. M., Al-Najjar B. O., Khanfar M. A., El-Abadelah M. M. Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity // Current Organic Synthesis. 2025. Vol. 21. No. 3. pp. 410-418.
RIS |
Цитировать
TY - JOUR
DO - 10.2174/0115701794335274240910111137
UR - https://www.eurekaselect.com/234292/article
TI - Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity
T2 - Current Organic Synthesis
AU - Al-Mahadeen, Mohammed M.
AU - Jaber, Areej Majed
AU - Al-Najjar, Belal O.
AU - Khanfar, Monther A.
AU - El-Abadelah, Mustafa M.
PY - 2025
DA - 2025/02/01
PB - Bentham Science Publishers Ltd.
SP - 410-418
IS - 3
VL - 21
SN - 1570-1794
SN - 1875-6271
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2025_Al-Mahadeen,
author = {Mohammed M. Al-Mahadeen and Areej Majed Jaber and Belal O. Al-Najjar and Monther A. Khanfar and Mustafa M. El-Abadelah},
title = {Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity},
journal = {Current Organic Synthesis},
year = {2025},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {feb},
url = {https://www.eurekaselect.com/234292/article},
number = {3},
pages = {410--418},
doi = {10.2174/0115701794335274240910111137}
}
MLA
Цитировать
Al-Mahadeen, Mohammed M., et al. “Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity.” Current Organic Synthesis, vol. 21, no. 3, Feb. 2025, pp. 410-418. https://www.eurekaselect.com/234292/article.